Cracking the code of a correlate of protection against SARS-CoV-2 breakthrough infection in cancer patients.
Source
Scientific reports - ISSN 2045-2322-15:1 (2025) p. 1-15
Long-term effects of the COVID-19 pandemic for patients with cancer
Source
Quality of life research - ISSN 0962-9343-33:10 (2024) p. 2845-2853
A real-world analysis on the efficacy and tolerability of liposomal irinotecan plus 5-fluorouracil and folinic acid in metastatic pancreatic ductal adenocarcinoma in Belgium
Source
Therapeutic advances in medical oncology - ISSN 1758-8340-15 (2023) p. 1-13
Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in patients with cancer
Source
Clinical cancer research - ISSN 1078-0432-29:3 (2023) p. 635-646
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors
Source
Frontiers in immunology - ISSN 1664-3224-13 (2022) p. 1-10